Targeting the Proteasome in Refractory Pediatric Leukemia Cells: Characterization of Effective Cytotoxicity of Carfilzomib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting the Proteasome in Refractory Pediatric Leukemia Cells: Characterization of Effective Cytotoxicity of Carfilzomib

Published:2018-11-16 Issue:6 Volume:13 Page:779-793
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Swift Lucy,Jayanthan Aarthi,Ruan Yibing,Anderson Ronald,Boklan Jessica,Trippett Tanya,Narendran Aru

Funder

POETIC Foundation

Alberta Children's Hospital Foundation

Kids Cancer Care Foundation of Alberta

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s11523-018-0603-0/fulltext.html

Reference54 articles.

1. Locatelli F, Schrappe M, Bernardo ME, Rutella S. How I treat relapsed childhood acute lymphoblastic leukemia. Blood. 2012;120(14):2807.

2. Rubnitz JE. How I treat pediatric acute myeloid leukemia. Blood. 2012;119(25):5980–8. https://doi.org/10.1182/blood-2012-02-392506 .

3. Davila J, Slotkin E, Renaud T. Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments. Paediatr Drugs. 2014;16(2):151–68. https://doi.org/10.1007/s40272-013-0048-y .

4. Lilienbaum A. Relationship between the proteasomal system and autophagy. Int J Biochem Mol Biol. 2013;4(1):1–26.

5. Nooka A, Gleason C, Casbourne D, Lonial S. Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomib. Biologics. 2013;7:13–32. https://doi.org/10.2147/btt.s24580 .

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carfilzomib‐based antibody mediated rejection therapy in pediatric kidney transplant recipients;Pediatric Transplantation;2023-05-02

2. Carfilzomib: Looking for ‘The Holy Grail’ to treat antibody‐mediated rejection;Pediatric Transplantation;2023-05-02

3. High Immunoproteasome Activity and sXBP1 in Pediatric Precursor B-ALL Predicts Sensitivity towards Proteasome Inhibitors;Cells;2021-10-22

4. Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib;Current Cancer Drug Targets;2021-10

5. RNA-binding protein 39: a promising therapeutic target for cancer;Cell Death Discovery;2021-08-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3